Bayesian modelling of combined FEV1 and FVC vital lung function trajectories: relationship with airflow obstruction and PRISm

Bayesian modelling of FEV1 and FVC trajectories

Introduction: Airflow Obstruction and PRISm Through Bayesian Modelling of FEV1 and FVC Trajectories

Previous studies have shown that there is a range of FEV1 trajectories across the lifespan. 

Yet, how trajectories defined by the combination of both FEV1 and FVC relate to airflow obstruction (AO; FEV1/FVC<0.7 and FEV1< 80% ref.) or Preserved Ratio Impaired Spirometry (PRISm; FEV1/FVC ≥ 0.7 and FEV1 < 80% ref.) is unknown.

Methods: Applying Bayesian Modelling to FEV1 and FVC Trajectories in the Framingham Offspring Cohort

We applied Bayesian non-parametric mixture modeling to data from the Framingham Offspring Cohort (FOC). Trajectory subgroups were identified by simultaneously modeling both pre-bronchodilator FEV1 and FVC (in liters) as a function of age and height.

We modeled all males >20 yr. (N=1,333). The prevalence of AO or PRISm and age of onset was compared across trajectories.

 

Results: Seven Distinct Trajectories Identified via Bayesian Modelling of FEV1 and FVC

This analysis identified seven FEV1 and FVC defined trajectories. 

Their description (Table1) was based on both measurements, which were in accordance with each other.

 

Conclusion: Associations Between Airflow Obstruction, PRISm, and Bayesian Modelled FEV1 and FVC Trajectories

Bayesian non-parametric trajectory modeling identified seven combined FEV1 and FVC life-course trajectories differentially associated to AO or PRISm.

Authors

Núria Olvera Ocaña, Àlvar Agustí, James Ross, Rosa Faner

Read more details at

Noticias relacionadas

Telomere length in patients with bronchiectasis

Telomere length in patients with bronchiectasis

This study investigates telomere length (TL) in bronchiectasis patients, comparing them to COPD patients and healthy controls. Findings show no significant TL reduction in bronchiectasis compared to controls, but a trend towards shorter TL in idiopathic cases. Further research is needed to understand TL’s role in bronchiectasis.

Leer más »
Metabolic Changes in COPD

Aging and Metabolic Changes in COPD Patients

Explore the metabolic changes in COPD patients, highlighting the influence of aging and sex, with pronounced effects in males. Discover how COPD affects protein metabolism and energy production, emphasizing early aging’s impact.

Leer más »

Artículos

Imagen desarrollada con Canva

Entérate de
Nuestras Publicaciones

Loading